CO4340678A1 - FORMULATIONS FOR PHARMACEUTICAL AGENTS ADMINISTERED IN ORAL FORM - Google Patents

FORMULATIONS FOR PHARMACEUTICAL AGENTS ADMINISTERED IN ORAL FORM

Info

Publication number
CO4340678A1
CO4340678A1 CO95007821A CO95007821A CO4340678A1 CO 4340678 A1 CO4340678 A1 CO 4340678A1 CO 95007821 A CO95007821 A CO 95007821A CO 95007821 A CO95007821 A CO 95007821A CO 4340678 A1 CO4340678 A1 CO 4340678A1
Authority
CO
Colombia
Prior art keywords
agent
formulations
pharmaceutical agents
agents administered
oral form
Prior art date
Application number
CO95007821A
Other languages
Spanish (es)
Inventor
Stephanie A Sweetana
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to CO95007821A priority Critical patent/CO4340678A1/en
Publication of CO4340678A1 publication Critical patent/CO4340678A1/en

Links

Abstract

REIVINDICACION NUMERO UNA FORMULACION SUBSTANCIALMENTE NO ACUOSA PARA ADMINISTRACION ORAL DE UN AGENTE FARMACEUTICO, CARACTERIZADA PORQUE COMPRENDE DE: (1) UN AGENTE FARMACEUTICO QUE ES SUBSTANCIALMENTE NO ACUOSO EN EL CUAL, EL AGUA Y (2) UN PORTADOR SUBSTANCIALMENTENO ACUOSO EN EL CUAL, EL AGENTE ESTA SOLUBILIZADO, EL PORTADOR COMPRENDE UN AGENTE SOLUBILIZANTE DE ACIDO GRASO DE CADENA LARGA, UN ACEITE ACEPTABLE FARMACEUTICAMENTE Y UN AGENTE ACTIVO DE SUPERFICIE".CLAIMED NUMBER A SUBSTANTIALLY NON-WATER FORMULATION FOR ORAL ADMINISTRATION OF A PHARMACEUTICAL AGENT, CHARACTERIZED BECAUSE IT INCLUDES: (1) A PHARMACEUTICAL AGENT WHO IS SUBSTANTIALLY NOT AQUATIC, THE WATER AND (2) A SUBSTANTIAL ELEMENTARY WATER AGENT IS SOLUBILIZED, THE CARRIER INCLUDES A LONG CHAIN FATTY ACID SOLUBILIZING AGENT, A PHARMACEUTICALLY ACCEPTABLE OIL AND AN ACTIVE SURFACE AGENT. "

CO95007821A 1995-02-28 1995-02-28 FORMULATIONS FOR PHARMACEUTICAL AGENTS ADMINISTERED IN ORAL FORM CO4340678A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CO95007821A CO4340678A1 (en) 1995-02-28 1995-02-28 FORMULATIONS FOR PHARMACEUTICAL AGENTS ADMINISTERED IN ORAL FORM

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CO95007821A CO4340678A1 (en) 1995-02-28 1995-02-28 FORMULATIONS FOR PHARMACEUTICAL AGENTS ADMINISTERED IN ORAL FORM

Publications (1)

Publication Number Publication Date
CO4340678A1 true CO4340678A1 (en) 1996-07-30

Family

ID=40909546

Family Applications (1)

Application Number Title Priority Date Filing Date
CO95007821A CO4340678A1 (en) 1995-02-28 1995-02-28 FORMULATIONS FOR PHARMACEUTICAL AGENTS ADMINISTERED IN ORAL FORM

Country Status (1)

Country Link
CO (1) CO4340678A1 (en)

Similar Documents

Publication Publication Date Title
ES2188782T3 (en) PHARMACEUTICAL FORMULATIONS CONTAINING DARIFENACINE.
ATE211387T1 (en) ORAL 1ALPHA-HYDROXYPREVITAMIN D
AR001739A1 (en) Use of a vasodilator for the production of a formulation to modulate the human sexual response and said formulation
CA2301017A1 (en) Use of propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
YU13695A (en) Application of 2-phenyl-3-aroylbenzothiophene and pharmaceutical formulations thereof
DE69842121D1 (en) OMEGA-3 FATTY ACID PHARMACEUTICAL COMPOSITIONS
DK0830145T3 (en) Formulations comprising leflunomide
ES2157975T3 (en) PHARMACEUTICAL SOLUTIONS WITH IMPROVED SOLUBILITY.
ES2156028T3 (en) Compositions containing tetrahydrolipstatin
IT8767796A0 (en) PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION WITH CONTROLLED DELIVERY OF AN ACTIVE INGREDIENT
PL325825A1 (en) Microemulsion for use as a carrier for administering active compounds
MY109512A (en) Pharmaceutical composition
AR037255A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING OXIBUTININE
DE3669106D1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING FLAVANOLIGNANES AND PHOSPHOLIPIDES AS ACTIVE INGREDIENTS.
ITMI913170A1 (en) PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC USE CONTAINING A NON-STEROID ANTI-INFLAMMATORY AND A DECONGESTANT AS ACTIVE INGREDIENTS
BR0010082A (en) Method for improving the effectiveness of an antitumor agent
IT1263840B (en) ORAL FORMULATIONS OF UBIDECARENONE IN THE FORM OF CAPSULES
NO950134L (en) Formulations for orally administered pharmaceutical agents
CO4340678A1 (en) FORMULATIONS FOR PHARMACEUTICAL AGENTS ADMINISTERED IN ORAL FORM
AU2809697A (en) Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
GB9420748D0 (en) 1,5 benzodiazepine derivatives
FR2750859B1 (en) PHARMACEUTICAL COMPOSITION INTENDED FOR ORAL ADMINISTRATION WITH ABSORPTION OF AT LEAST ONE ACTIVE INGREDIENT THROUGH THE MUCOSA OF THE MOUTH
ECSP982396A (en) COMPOSITIONS CONTAINING TETRAHYDROLYPSTATIN
CO4180553A1 (en) COMPOSITIONS FOR THE TREATMENT OF ADULT PERIDONTITIS
MY117556A (en) Methods and formulations for modulating the human sexual response